aCGH Impacts Survival in Plasma Cell PTLD

Civil Hospices of Lyon

Status: Completed

Conditions: Post-transplantation Lymphoproliferative Disorders

Study type: Observational

Funder types: Other

Identifiers

NCT02984215

69HCL16_0720

Details and patient eligibility

About

Plasma-cell post-transplantation lymphoproliferative disorders (PC-PTLD) are rare monomorphic PTLD divided into plasma cell myeloma (PCM) and plasmacytoma-like lesion (PLL) PTLD. To date, there is no exhaustive published cytogenetic data on PC-PTLD. The investigators report array-based comparative genomic hybridization (aCGH) of 10 cases of PCM and PLL-PTLD.

Enrollment: 10 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• WHO classification 2008 as monomorphic PCM (plasma cell myeloma) or PLL (plasmacytoma like lesion) / PTLD (post transplantation lymphoproliferative disorders).

Exclusion criteria

• Other than PCM or PLL PTLD at diagnosis